Fas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data
<p>Abstract</p> <p>Background</p> <p>During carcinogenesis, tumors develop multiple mechanisms for evading the immune response, including upregulation of Fas ligand (FasL/CD95L) expression. Expression of FasL may help to maintain tumor cells in a state of immune privile...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2006-02-01
|
| Series: | Journal of Carcinogenesis |
| Online Access: | http://www.carcinogenesis.com/content/5/1/5 |